The combination of trimethoprim and sulfamethoxazole is effective against which of the following oppounistic infections in the AIDS patient?
**Core Concept**
The combination of trimethoprim and sulfamethoxazole is a synergistic antimicrobial agent effective against opportunistic infections in immunocompromised patients, particularly those with HIV/AIDS. This combination works by inhibiting dihydrofolate reductase (DHFR) and dihydropteroate synthase enzymes, respectively, disrupting folic acid synthesis essential for bacterial growth.
**Why the Correct Answer is Right**
Trimethoprim-sulfamethoxazole (TMP-SMX) is effective against Pneumocystis jirovecii pneumonia (PCP), a common opportunistic infection in AIDS patients. The combination inhibits the growth of P. jirovecii by blocking the synthesis of tetrahydrofolate, a crucial precursor for DNA synthesis. TMP-SMX is also effective against other opportunistic pathogens, including Toxoplasma gondii and certain species of bacteria, but its efficacy against PCP is particularly notable.
**Why Each Wrong Option is Incorrect**
* **Option A:** TMP-SMX is not primarily used for treating Mycobacterium avium complex (MAC) infections, which typically require macrolide or rifabutin-based therapy.
* **Option B:** TMP-SMX is not the first-line treatment for Cryptococcal meningitis, which is usually managed with amphotericin B and flucytosine.
* **Option C:** TMP-SMX is not the primary treatment for Cytomegalovirus (CMV) retinitis, which is typically treated with ganciclovir or foscarnet.
**Clinical Pearl / High-Yield Fact**
Remember that TMP-SMX is a key component of the prophylaxis regimen for PCP in HIV/AIDS patients, and its use can be associated with adverse effects such as rash, fever, and hematologic abnormalities.
**Correct Answer:** C.